We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Microscopy Compared for Routine Malaria Diagnosis

By LabMedica International staff writers
Posted on 10 Oct 2018
Print article
Image: The Autoscope uses deep-learning software to quantify the malaria parasites in a sample (Photo courtesy of Intellectual Ventures).
Image: The Autoscope uses deep-learning software to quantify the malaria parasites in a sample (Photo courtesy of Intellectual Ventures).
Microscopic examination of Giemsa-stained blood films remains a major form of diagnosis in malaria case management. However, as with other visualization-based diagnoses, accuracy depends on individual technician performance, making standardization difficult and reliability poor.

Automated image recognition based on machine-learning, utilizing convolutional neural networks, offers potential to overcome these drawbacks. The application of digital image recognition to malaria microscopy, using artificial intelligence algorithms to replace or supplement the human factor in blood film interpretation, have been attempted, usually on thin films.

A team of scientists collaborating with Intellectual Ventures (Bellevue, WA, USA) conducted a cross-sectional, observational trial was conducted at two peripheral primary health facilities in Peru. They enrolled 700 participants whose age was between 5 and 75 years, and had a history of fever in the last three days or elevated temperature on admission. A finger prick blood sample was taken to create blood films for microscopy diagnosis, and additional drops of blood were spotted onto filter paper for subsequent quantitative polymerase chain reaction (qPCR) analysis. A prototype digital microscope device employing an algorithm based on machine-learning, the Autoscope, was assessed for its potential in malaria microscopy.

The investigators reported that at one clinic, sensitivity of Autoscope for diagnosing malaria was 72% and specificity was 85%. Microscopy performance was similar to Autoscope, with sensitivity 68% and specificity 100%. At one clinic, 85% of prepared slides had a minimum of 600 white blood cells (WBCs) imaged, thus meeting Autoscope’s design assumptions. At the second clinic, the sensitivity of Autoscope was 52% and specificity was 70%. Microscopy performance at this second clinic was 42% and specificity was 97%. Only 39% of slides from this clinic met Autoscope’s design assumptions regarding WBCs imaged.

The authors concluded that Autoscope’s diagnostic performance was on par with routine microscopy when slides had adequate blood volume to meet its design assumptions, as represented by results from one clinic. Autoscope’s diagnostic performance was poorer than routine microscopy on slides from the other clinic, which generated slides with lower blood volumes. The study was published on September 25, 2018, in the Malaria Journal.

Related Links:
Intellectual Ventures

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Chagas Disease Test
LIAISON Chagas

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more